Literature DB >> 25473353

Retino-choroidal ischemia in central retinal vein occlusion.

Nazimul Hussain1, Anjli Hussain2.   

Abstract

A 41-year-old gentleman with insulin dependent diabetes had decreased vision in the right eye due to non-ischemic central retinal vein occlusion with macular edema. One month following intravitreal ranibizumab, he developed retino-choroidal ischemia with further loss of vision. Authors show the fluorescein angiographic transition from non-ischemic central retinal vein occlusion to retino-choroidal ischemia.

Entities:  

Keywords:  Central retinal vein occlusion; Macular edema; Retinochoroidal ischemia

Year:  2014        PMID: 25473353      PMCID: PMC4250501          DOI: 10.1016/j.sjopt.2014.02.004

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  16 in total

Review 1.  Serous detachment of the retina.

Authors:  Richard F Spaide; Mauro Goldbaum; Doric W K Wong; Kong Chan Tang; Tomohiro Iida
Journal:  Retina       Date:  2003-12       Impact factor: 4.256

2.  Retinochoroidal infarction during the treatment of acute lymphoblastic leukemia.

Authors:  Yoko Kato; Yoko Takano; Masahisa Kobayashi; Fumiyuki Ito; Takaaki Hara; Takaaki Yanagisawa; Yasutaka Hoshi; Yoshikatsu Eto
Journal:  Pediatr Int       Date:  2006-10       Impact factor: 1.524

3.  Re: "Anterior segment ischemia and retinochoroidal vascular occlusion after intralesional steroid injection".

Authors:  Shahriar Amjadi; Tani M Brown; Katherine Masselos; Louis W Wang; Edwin C Figueira; Ian C Francis
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2009 May-Jun       Impact factor: 1.746

4.  Visual problems as a presenting sign of thrombotic thrombocytopenic purpura.

Authors:  R C Melton; R F Spaide
Journal:  Retina       Date:  1996       Impact factor: 4.256

5.  Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials.

Authors:  Rohit Varma; Neil M Bressler; Ivan Suñer; Paul Lee; Chantal M Dolan; James Ward; Shoshana Colman; Roman G Rubio
Journal:  Ophthalmology       Date:  2012-07-18       Impact factor: 12.079

6.  Hyperhomocysteinemia, as an independent risk factor for retinal venous occlusion in an Indian population.

Authors:  Kapil D Lahiri; Jayanta Dutta; Himadri Datta; Harendra N Das
Journal:  Indian J Clin Biochem       Date:  2012-07-04

7.  Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.

Authors:  Peter A Campochiaro; David M Brown; Carl C Awh; S Young Lee; Sarah Gray; Namrata Saroj; Wendy Yee Murahashi; Roman G Rubio
Journal:  Ophthalmology       Date:  2011-06-29       Impact factor: 12.079

8.  Anterior segment ischemia and retinochoroidal vascular occlusion after intralesional steroid injection.

Authors:  Ayşe Yağci; Melis Palamar; Sait Eğrilmez; Cahit Sahbazov; Süha Sureyya Ozbek
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2008 Jan-Feb       Impact factor: 1.746

9.  Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-05

10.  Choroidal ischemia.

Authors:  A Gaudric; G Coscas; A C Bird
Journal:  Am J Ophthalmol       Date:  1982-10       Impact factor: 5.258

View more
  1 in total

1.  A causal mediation model of ischemia reperfusion injury in the retina.

Authors:  Maha Soliman; Kalina Andreeva; Olfa Nasraoui; Nigel G F Cooper
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.